Founded in 1994, Bavarian Nordic has through the last fifteen
years built a solid platform for developing modern vaccines for the
treatment and prevention of life-threatening diseases.
Our proprietary MVA-BN® vaccine vector technology with its
unique safety profile is the foundation for most of the company's
vaccines and with the world's only dedicated facility for the
manufacturing of MVA vaccines, the company is leading in the field
of MVA.
Our core competences are:
